CIEFFE DERMA

MACROCEA COMBI SOLUTION 5 ML + CREAM 8 ML

MACROCEA COMBI SOLUTION 5 ML + CREAM 8 ML

Skip to product information
1 of 1
  • Secure payment
  • Discreet and sanitized package
  • Fast and safe shipping

Description

Descriptive sheet

Macrocea

Description
Modular product that includes: a glycerin + KOH solution capable of carrying out an effective action against warts or molluscum contagiosum and an antiseptic cream to enhance and complete the virucidal action of the treatment.
Phase A (SOLUTION) is used externally on molluscum contagiosum and common warts, skin lesions caused by viral infections.
The highly alkaline solution dissolves the cells affected by the virus, thus activating a skin defense reaction in the affected area. The goal of the treatment is to stimulate a local and painless inflammatory response, thus calling on the immune system to fight the infection.
The combined and sequential application of phase B (CREAM) promotes the action of the immune system and the antiseptic activity of the treatment, amplifying its effects and reducing the duration of therapy.

Components
Cream: aqua, propanediol, glycerin, xanthan gum, caprylic/capric triglyceride, tocopherol, lactoferrin, epigallocatechin gallate, lysozyme hydrochloride, hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, ethylhexylglycerin, chloroxylenol, phenethyl alcohol, Polygonum cuspidatum extract, polydatin, caprylyl glycol, ectoin, polyisobutene, glycogen, PEG 7 trimethylolpropane coconut ether, lecithin, sorbitan isostearate, lactic acid, Echinacea purpurea flower/leaf/stem extract, citric acid, ascorbyl palmitate, maltodextrin.
Solution: aqua, glycerin, potassium hydroxide.

Warnings
Phase A (SOLUTION) must not be used:
- in infants and children under 2 years of age;
- when there is a known tendency to form excess scar tissue (hypertrophic scars, keloids);
- in people with congenital or acquired immunodeficiency (for example, HIV infection or treatment with drugs that suppress the immune system);
- in the region around the eyes, nose and mouth;
- on the mucous membranes (e.g. mouth or genital region);
- on open wounds or scratched skin;
- on already inflamed molluscum contagiosum and/or warts.
If Phase A (SOLUTION) comes into contact with any of these areas, rinse immediately with plenty of water. Always store out of reach of children, in an upright position, and tightly closed. Transient reactions with redness and itching in the treated area indicate that the treatment is taking effect.
Short-term skin irritation and mild burning may occur immediately after application and usually subside after a few minutes.
The intensity of skin irritation depends on the sensitivity of the skin and the amount of solution applied.

Conservation
Shelf life after opening the cream: 6 months.
Shelf life after opening lotion: 28 days.

Format
8 ml cream and 5 ml solution.

Cod. 7053

CIEFFE DERMA

MACROCEA COMBI SOLUTION 5 ML + CREAM 8 ML

MACROCEA COMBI SOLUTION 5 ML + CREAM 8 ML

MINSAN code: 988067082
Previous price: €19,27
Regular price €19,27
Regular price €19,50 Sale price €19,27
-1% Sold out
Tax included. Shipping calculated at checkout.
View full details

Product images are purely indicative and may not be fully representative of the packaging and product features, as they may vary in color, size, or content. Any decorations, gift wrapping, and items included in the images for product presentation purposes will not be shipped with orders. Product names, ingredients, and percentages indicated in the descriptions are purely indicative and may be subject to change or updates by the manufacturers. Due to the impossibility of updating these updates in real time, the photos and technical information of the products listed on farmaInnovation.it may differ from those shown on the label or otherwise disclosed by the manufacturers. The only identifying element is the MINSAN (Ministry of Health) code. Farmacia Barni, farmainnovation.it , does not guarantee the accuracy and timeliness of the information published and declines all responsibility for any errors, omissions, or failure to update it. farmainnovation.it assumes no responsibility for damages of any kind that may arise from accessing the published information.